These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 12324668

  • 1. Effects of hypertonic saline, alternate day and daily rhDNase on healthcare use, costs and outcomes in children with cystic fibrosis.
    Suri R, Grieve R, Normand C, Metcalfe C, Thompson S, Wallis C, Bush A.
    Thorax; 2002 Oct; 57(10):841-6. PubMed ID: 12324668
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A cost-effectiveness analysis of rhDNase in children with cystic fibrosis.
    Grieve R, Thompson S, Normand C, Suri R, Bush A, Wallis C.
    Int J Technol Assess Health Care; 2003 Oct; 19(1):71-9. PubMed ID: 12701940
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Nebulised hypertonic saline for cystic fibrosis.
    Wark P, McDonald VM.
    Cochrane Database Syst Rev; 2009 Apr 15; (2):CD001506. PubMed ID: 19370568
    [Abstract] [Full Text] [Related]

  • 9. The use of human deoxyribonuclease (rhDNase) in the management of cystic fibrosis.
    Suri R.
    BioDrugs; 2005 Apr 15; 19(3):135-44. PubMed ID: 15984899
    [Abstract] [Full Text] [Related]

  • 10. Recombinant human deoxyribonuclease for cystic fibrosis.
    Jones AP, Wallis CE.
    Cochrane Database Syst Rev; 2003 Apr 15; (3):CD001127. PubMed ID: 12917899
    [Abstract] [Full Text] [Related]

  • 11. Effects of recombinant human DNase therapy on healthcare use and costs in patients with cystic fibrosis.
    Oster G, Huse DM, Lacey MJ, Regan MM, Fuchs HJ.
    Ann Pharmacother; 1995 May 15; 29(5):459-64. PubMed ID: 7655127
    [Abstract] [Full Text] [Related]

  • 12. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group.
    Fuchs HJ, Borowitz DS, Christiansen DH, Morris EM, Nash ML, Ramsey BW, Rosenstein BJ, Smith AL, Wohl ME.
    N Engl J Med; 1994 Sep 08; 331(10):637-42. PubMed ID: 7503821
    [Abstract] [Full Text] [Related]

  • 13. Comparison of inhaled mannitol, daily rhDNase and a combination of both in children with cystic fibrosis: a randomised trial.
    Minasian C, Wallis C, Metcalfe C, Bush A.
    Thorax; 2010 Jan 08; 65(1):51-6. PubMed ID: 19996349
    [Abstract] [Full Text] [Related]

  • 14. Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis.
    Eng PA, Morton J, Douglass JA, Riedler J, Wilson J, Robertson CF.
    Pediatr Pulmonol; 1996 Feb 08; 21(2):77-83. PubMed ID: 8882210
    [Abstract] [Full Text] [Related]

  • 15. [Socioeconomic evaluation of the effect of rhDNase on the cost of treating infections of the respiratory tract in patients with cystic fibrosis].
    von der Schulenburg JM, Greiner W, von der Hardt H.
    Med Klin (Munich); 1995 Apr 15; 90(4):220-4. PubMed ID: 7776934
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of short-term administration of aerosolised recombinant human DNase I in adults with stable stage cystic fibrosis.
    Ranasinha C, Assoufi B, Shak S, Christiansen D, Fuchs H, Empey D, Geddes D, Hodson M.
    Lancet; 1993 Jul 24; 342(8865):199-202. PubMed ID: 8100928
    [Abstract] [Full Text] [Related]

  • 17. rhDNase therapy for the treatment of cystic fibrosis patients with mild to moderate lung disease.
    Christopher F, Chase D, Stein K, Milne R.
    J Clin Pharm Ther; 1999 Dec 24; 24(6):415-26. PubMed ID: 10651974
    [Abstract] [Full Text] [Related]

  • 18. Assessing the usefulness of outcomes measured in a cystic fibrosis treatment trial.
    Suri R, Metcalfe C, Wallis C, Bush A.
    Respir Med; 2007 Feb 24; 101(2):254-60. PubMed ID: 16806875
    [Abstract] [Full Text] [Related]

  • 19. Medium term treatment of stable stage cystic fibrosis with recombinant human DNase I.
    Shah PL, Scott SF, Fuchs HJ, Geddes DM, Hodson ME.
    Thorax; 1995 Apr 24; 50(4):333-8. PubMed ID: 7785003
    [Abstract] [Full Text] [Related]

  • 20. Use of rhDNase therapy and costs of respiratory-related care in patients with cystic fibrosis.
    Ollendorf DA, McGarry LJ, Watrous ML, Oster G.
    Ann Pharmacother; 2000 Mar 24; 34(3):304-8. PubMed ID: 10917374
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.